National Jewish Health

National Jewish Health is the leading respiratory hospital in the nation. Founded in 1899 as a nonprofit hospital, National Jewish Health today is the only facility in the world dedicated exclusively to groundbreaking medical research and treatment of patients with respiratory, cardiac, immune, and related disorders. The world-class faculty and staff at National Jewish Health are leaders in their field and provide the most up-to-date and evidence-based education on respiratory diseases, including asthma, allergy, infectious disease, COPD, COVID-19, interstitial lung disease, as well as cardiology, rheumatology, sleep, and various others. The CME Program at National Jewish Health is managed and executed by the Office of Professional Education. For access to additional educational programs please go to National Jewish Health CME.

For more information on National Jewish Health and the diseases we research and treat please go to Home.
To receive email updates on upcoming events and online CME courses, join the mailing list here.

 

Journal Club
29:19

National Jewish Health

Time to Positive Culture Detection Predicts Mycobacterium Avium Pulmonary Disease Severity and Treatment Initiation

FEATURING Shannon Kasperbauer
  • 175 views
  • August 26, 2022
24:20

National Jewish Health

Safety and Efficacy of Rituximab in Systemic Sclerosis (DESIRES): A Double-Blind, Investigator-Initiated, Randomised, Placebo-Controlled Trial

FEATURING Mehrnaz Maleki Fischbach
  • 380 views
  • August 18, 2022
30:42

National Jewish Health

Consensus Management Recommendations for Less Common Non-Tuberculous Mycobacterial Pulmonary Diseases

FEATURING Charles Daley
  • 298 views
  • July 28, 2022
  • 2
29:00

National Jewish Health

The Impact of Disease Severity Measures on Survival in U.S. Veterans With Rheumatoid Arthritis - Associated Interstitial Lung Disease

FEATURING Isabelle Amigues
  • 231 views
  • July 19, 2022
  • 1
23:17

National Jewish Health

Host and Pathogen Response to Bacteriophage Engineered Against Mycobacterium Abscessus Lung Infection

FEATURING Jerry Nick
  • 125 views
  • July 5, 2022
  • 1
20:53

National Jewish Health

Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis

FEATURING Rebecca Keith
  • 455 views
  • June 23, 2022
  • 2
27:39

National Jewish Health

Genomic Analysis of a Hospital-Associated Outbreak of Mycobacterium Abscessus: Implications on Transmission

FEATURING Rebecca Davidson
  • 140 views
  • May 27, 2022
  • 2
34:05

National Jewish Health

The Role of Genetic Testing in Pulmonary Fibrosis: A Perspective From the Pulmonary Fibrosis Foundation Genetic Testing Work Group

FEATURING Zulma Yunt, Janet Talbert
  • 248 views
  • May 13, 2022
  • 2
26:24

National Jewish Health

Mycobacterium Abscessus Biofilms Have Viscoelastic Properties Which May Contribute to Their Recalcitrance in Chronic Pulmonary Infections

FEATURING Jenn Honda
  • 124 views
  • May 5, 2022
  • 1
28:21

National Jewish Health

Long-Term Treatment With Human Immunoglobulin for Antisynthetase Syndrome-Associated Interstitial Lung Disease

FEATURING Liudmila Kastsianok, Jinny Tavee
  • 82 views
  • April 22, 2022
24:07

National Jewish Health

Pilot Study to Test Inhaled Nitric Oxide in Cystic Fibrosis Patients With Refractory Mycobacterium Abscessus Lung Infection

FEATURING Jane Gross
  • 119 views
  • April 5, 2022
  • 1
26:52

National Jewish Health

Inhaled Treprostinil and Forced Vital Capacity in Patients With ILD and Associated Pulmonary Hypertension: A Post-hoc Analysis of the INCREASE Study

FEATURING Mohammad Dalabih
  • 182 views
  • March 22, 2022
27:03

National Jewish Health

Diagnostic Accuracy of Endobronchial Optical Coherence Tomography for the Microscopic Diagnosis of Usual Interstitial Pneumonia

FEATURING Rebecca Keith, Lida Hariri
  • 84 views
  • March 10, 2022
36:37

National Jewish Health

Mycobacteriophage-Antibiotic Therapy Promotes Enhanced Clearance of Drug-Resistant Mycobacterium Abscessus

FEATURING Michael Strong
  • 216 views
  • February 28, 2022
  • 3
23:58

National Jewish Health

Sotatercept for the Treatment of Pulmonary Arterial Hypertension

FEATURING Mohammad Dalabih, Patricia George
  • 713 views
  • February 22, 2022
  • 3
30:06

National Jewish Health

Leukocyte Telomere Length and Mycophenolate Therapy in Chronic Hypersensitivity Pneumonitis

FEATURING Matthew Koslow, Ayodeji Adegunsoye
  • 328 views
  • February 11, 2022
  • 4
22:35

National Jewish Health

Preliminary, Real-World, Multicenter Experience With Omadacycline for Mycobacterium Abscessus Infections

FEATURING Jared Eddy
  • 163 views
  • January 31, 2022
13:57

National Jewish Health

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases: Study Highlights

FEATURING Rebecca Keith
  • 429 views
  • December 16, 2021
  • 1
20:34

National Jewish Health

Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry

FEATURING Steve Lommatzsch
  • 370 views
  • December 2, 2021
  • 3
18:00

National Jewish Health

Comparative Efficacy and Safety of Targeted Therapies for Chronic Thromboembolic Pulmonary Hypertension: Study Review

FEATURING Mohammad Dalabih
  • 215 views
  • November 23, 2021
  • 1
20:26

National Jewish Health

Avacopan for the Treatment of ANCA-Associated Vasculitis: Study Discussion

FEATURING Mehrnaz Maleki-Fischbach
  • 217 views
  • November 17, 2021
  • 1
13:36

National Jewish Health

Chronic Non-Invasive Ventilation for Chronic Obstructive Pulmonary Disease: Study Discussion

FEATURING James P. Woodrow
  • 403 views
  • November 10, 2021
  • 1
14:03

National Jewish Health

Study Discussion on ALIS for Refractory MAC Lung Disease: Sustainability and Durability of Culture Conversion and Safety of Long-Term Exposure

FEATURING Shannon Kasperbauer
  • 152 views
  • October 28, 2021
  • 1
17:51

National Jewish Health

Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia: Study Review

FEATURING Rebecca Keith
  • 164 views
  • October 14, 2021
  • 1
10:36

National Jewish Health

C-Reactive Protein Testing to Guide Antibiotic Prescribing for COPD Exacerbations: Study Discussion

FEATURING Ann Granchelli
  • 1,104 views
  • October 7, 2021
  • 7
16:59

National Jewish Health

Phase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis: Study Review

FEATURING Charles Daley
  • 333 views
  • October 5, 2021
  • 2
13:59

National Jewish Health

Inhaled Nitric Oxide in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis: Study Discussion

FEATURING Mohammad Dalabih
  • 247 views
  • September 24, 2021
  • 1
17:31

National Jewish Health

Tocilizumab in Systemic Sclerosis: FocuSSed Trial Study Discussion

FEATURING Liudmila Kastsianok, Rebecca Keith
  • 261 views
  • September 23, 2021
  • 3
16:57

National Jewish Health

Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality: Study Discussion

FEATURING James P. Woodrow
  • 218 views
  • September 15, 2021
  • 1
24:34

National Jewish Health

ALIS for Treatment-Refractory Lung Disease Caused by MAC: CONVERT Study Review

FEATURING David Griffith
  • 324 views
  • August 31, 2021
  • 2
13:10

National Jewish Health

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease: Study Discussion

FEATURING Mohammad Dalabih
  • 301 views
  • August 24, 2021
  • 1
27:07

National Jewish Health

Ambulatory Oxygen for Fibrotic ILD: AmbOx Trial Discussion

FEATURING Matthew Koslow, Jeffrey Swigris
  • 283 views
  • August 17, 2021
  • 1
16:07

National Jewish Health

Triple Inhaled Therapy in COPD: Current Guidelines, Benefits/Risks, and ETHOS Trial Discussion

FEATURING James P. Woodrow
  • 5,031 views
  • August 12, 2021
  • 25